Physician profile
Travis M Brewer
NPI 1669768636
$2,407.62
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,277 · 2023: $1,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.64 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $432.01 | 2022-2023 | Jardiance, Emgality, Mounjaro |
| Novo Nordisk INC | $362.00 | 2022-2023 | Rybelsus, Ozempic, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $170.09 | 2022-2023 | Trintellix |
| Abbvie INC. | $169.56 | 2022-2023 | |
| Glaxosmithkline, LLC. | $154.68 | 2022-2023 | Trelegy Ellipta, Shingrix |
| Astellas Pharma US INC | $139.88 | 2022-2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $122.64 | 2022-2023 | Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $103.26 | 2022 | |
| Exact Sciences Corporation | $93.31 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $90.54 | 2022-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $78.95 | 2022 | |
| Esperion Therapeutics, INC. | $54.42 | 2023 | Nexletol |
| Amneal Pharmaceuticals LLC | $45.46 | 2022-2023 | Unithroid |
| Boston Scientific Corporation | $36.37 | 2022 | |
| Idorsia Pharmaceuticals US INC | $33.77 | 2023 | Quviviq |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.56 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.44 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.41 | 2023 | Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $23.89 | 2022 | |
| Amarin Pharma, INC. | $19.48 | 2022 | |
| Eisai INC. | $18.90 | 2022 | |
| Stryker Corporation | $18.28 | 2023 | Anchorage, Infinity, Ortholoc 2 Lapifuse |
| Phadia US INC. | $17.19 | 2023 | Immunocap |
| Ironwood Pharmaceuticals, INC | $17.16 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.01 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.82 | 2023 | |
| Supernus Pharmaceuticals, INC. | $16.11 | 2023 | Qelbree |
| Amgen INC. | $15.48 | 2023 | Repatha, Otezla |
| Tris Pharma INC | $15.06 | 2023 | Dyanavel Xr |
| Jazz Pharmaceuticals INC. | $14.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.58 | 2023 | Spravato |
| Kowa Pharmaceuticals America, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.